Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells

BACKGROUND: The pharmacologic modulatory effects of the antibiotic, tunicamycin (TM), on multidrug-resistant human UWOV2 ovarian cancer cells are reported. The UWOV2 cell line was derived from a cystadenocarcinoma in a patient refractory to combination chemotherapy with actinomycin D, vincristine (V...

Descripción completa

Detalles Bibliográficos
Autores principales: Hiss, Donavon C, Gabriels, Gary A, Folb, Peter I
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865531/
https://www.ncbi.nlm.nih.gov/pubmed/17439664
http://dx.doi.org/10.1186/1475-2867-7-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1865531/
https://www.ncbi.nlm.nih.gov/pubmed/17439664
http://dx.doi.org/10.1186/1475-2867-7-5

Ejemplares similares